SCHEMBL29005173

SCHEMBL29005173

CCOC(=O)C(NC(=O)OC(C)(C)C)C(=O)NC(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
MAPT P10636 3/20 0.54
GAA P10253 2/20 0.48
KDM4E B2RXH2 1/20 0.48
PKM P14618 1/20 0.48
HPGD P15428 1/20 0.48
ALOX12 P18054 1/20 0.48
S1PR3 Q99500 2/20 0.46
LMNA P02545 3/20 0.44
CYP1A2 P05177 2/20 0.42
HTT P42858 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PPARA Q07869 2/20 0.41
TSHR P16473 2/20 0.41
ABCB11 O95342 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR2A P28223 1/20 0.41
PMP22 Q01453 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29005338 0.85 S1PR3 (0.51) ALDH1A1MAPTGAAKDM4EPKM
SCHEMBL25015331 0.81 ALDH1A1 (0.60) ALDH1A1MAPTGAAKDM4EPKM
SCHEMBL25015984 0.78 ALDH1A1 (0.54) ALDH1A1MAPTGAAKDM4EPKM
SCHEMBL30342159 0.78 MAPT (0.48) ALDH1A1MAPTGAAKDM4EPKM
SCHEMBL561366 0.76 CYP1A2 (0.55) ALDH1A1MAPTGAAKDM4EPKM
SCHEMBL21603014 0.75 CYP1A2 (0.49) ALDH1A1MAPTLMNACYP1A2HTT
SCHEMBL29780735 0.74 ALDH1A1 (0.64) ALDH1A1MAPTGAAKDM4EPKM
SCHEMBL7964056 0.74 CTSK (0.46) MAPTCTSSCTSK
SCHEMBL28985217 0.73 CYP1A2 (0.52) ALDH1A1MAPTGAAKDM4EPKM
SCHEMBL996287 0.73 CTSS (0.58) ALDH1A1MAPTGAAKDM4ES1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116134018-A 2-oxoimidazolidine-4-carboxamide as NAV1.8 inhibitor 默沙东有限责任公司 2023-05-16 CN disclosed